ApprovalTrail

Drug · DIN 02408619

MINT-DONEPEZIL

Yes: authorized and sold in Canada

Authorized, and the company reports that it sells it in Canada.

Status Marketed since June 11, 2019; first marketed June 11, 2019.
Drug Identification Number (DIN)
02408619
Company (DIN owner)
Mint Pharmaceuticals IncMississauga, Ontario, Canada
Schedule
Prescription
Dosage form
Tablet
Route
Oral
Therapeutic class (ATC)
Donepezil N06DA02
Class
Human
Record last updated
June 18, 2026

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
DONEPEZIL HYDROCHLORIDE10 MG

Notices of Compliance

Health Canada approvals that name this DIN.

Other DINs named MINT-DONEPEZIL